Wipfli Financial Advisors’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History

Wipfli Financial Advisors’s Portfolio TARO Stock Details TARO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	$21K	Buy	+711	New	+$24.5K	﹤0.01%	1563

Other funds holding TARO

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

KAM

Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

BIP

Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wipfli Financial Advisors's TARO Position: Q3 2022 in Review

Wipfli Financial Advisors opened a new position in Taro Pharmaceutical Industries Ltd. (TARO) in Q3 2022: 711 shares worth $21K. The stake represents ﹤0.01% of the portfolio and ranks #1563 among its holdings.

71 funds tracked by Wall St. Rank hold TARO as of Q3 2022.

Wipfli Financial Advisors held 711 shares of Taro Pharmaceutical Industries Ltd. worth $21K as of Q3 2022.
Taro Pharmaceutical Industries Ltd. was a new Wipfli Financial Advisors position in Q3 2022.
Taro Pharmaceutical Industries Ltd. made up ﹤0.01% of Wipfli Financial Advisors's portfolio in Q3 2022, its #1563 holding.
71 funds tracked by Wall St. Rank held Taro Pharmaceutical Industries Ltd. as of Q3 2022.

Based on Wipfli Financial Advisors's 13F filing for Q3 2022, filed 26 Oct 2022.